Answers are grounded in this paper and cite their sources.
Evaluates a novel small molecule inhibitor tracer targeting HSP90 in cancer, suggesting clinical application benefits.
∼ 5). This probe supports comprehensive cancer management and may guide clinical application of emerging HSP90 inhibitors.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: